Sign Up Today and Learn More About CAMP4 Therapeutics Stock
Invest in or calculate the value of your shares in CAMP4 Therapeutics or other pre-IPO companies through EquityZen's platform.
CAMP4 Therapeutics Stock (CAFT)
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
About CAMP4 Therapeutics Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
CAMP4 Therapeutics Press Mentions
Stay in the know about the latest news on CAMP4 Therapeutics
Camp4 Therapeutics opens at $11.16, IPO priced at $11 per share
thefly • Oct 11, 2024
Methods of modulating progranulin expression using antisense oligonucleotides …
patents • Apr 14, 2024
Characterizing functional regulatory elements using machine learning
patents • Apr 14, 2024
Modulation of gene transcription using antisense oligonucleotides targeting …
patents • Apr 14, 2024
Modulation of gene transcription using antisense oligonucleotides targeting …
patents • Apr 14, 2024
CAMP4 Therapeutics Management
Leadership team at CAMP4 Therapeutics
CEO
Josh Mandel-Brehm
Founder
Leonard Zon
Join now and verify your accreditation status to gain access to:
- CAMP4 Therapeutics current valuation
- CAMP4 Therapeutics stock price
- Available deals in CAMP4 Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in CAMP4 Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like CAMP4 Therapeutics through EquityZen funds. These investments are made available by existing CAMP4 Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CAMP4 Therapeutics stock?
Shareholders can sell their CAMP4 Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
